HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Herrington, C S Search for Related Content PubMed PubMed Citation Articles by Herrington, C S

What we could do now: molecular pathology of gynaecological cancer

Department of Pathology, Duncan Building, Royal Liverpool University of Hospital, Daulby Street, Liverpool L69 3GA, UK

Correspondence: Professor Herrington c.s.herrington{at}liv.ac.uk

Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment—for example, therapeutic vaccination for human papillomavirus related disease.

Key Words: gynaecology • cancer • papillomavirus

This article has been cited by other articles:

				I Tomlinson Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview Mol. Pathol., August 1, 2001; 54(4): 201 - 202. [Full Text] [PDF]